Healthcare Infection Control Practices Advisory Committee (HICPAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This is a virtual meeting. The public is welcomed to listen to the meeting live via webcast on the World Wide Web. The webcast link can be found on the HICPAC website at www.cdc.gov/hicpac/meeting.html. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 194 (Tuesday, October 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 194 (Tuesday, October 10, 2023)]
[Notices]
[Page 69931]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22327]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Healthcare Infection Control Practices Advisory Committee (HICPAC).
This is a virtual meeting. The public is welcomed to listen to the
meeting live via webcast on the World Wide Web. The webcast link can be
found on the HICPAC website at <a href="http://www.cdc.gov/hicpac/meeting.html">www.cdc.gov/hicpac/meeting.html</a>. Time
will be available for public comment.
DATES: The meeting will be held on November 2, 2023, 9 a.m. to 5 p.m.,
EDT, and November 3, 2023, 9 a.m. to 12 p.m., EDT.
ADDRESSES: The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the HICPAC website at <a href="http://www.cdc.gov/hicpac/meeting.html">www.cdc.gov/hicpac/meeting.html</a>.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE,
Mailstop H16-3, Atlanta, Georgia 30329, Telephone (404) 718-8039.
Email: <a href="/cdn-cgi/l/email-protection#b4dcddd7c4d5d7f4d7d0d79ad3dbc2"><span class="__cf_email__" data-cfemail="f79f9e94879694b7949394d9909881">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: the
Isolation Precautions Guideline workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, and
the National Healthcare Safety Network (NHSN) Workgroup. The agenda
also includes updates on CDC and DHQP activities. Agenda items are
subject to change as priorities dictate.
Public Participation
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the following procedures: All persons
interested in making an oral public comment at the November 2-3, 2023
HICPAC meeting must submit a request between October 2, 2023 and
October 22, 2023, at <a href="https://www.cdc.gov/hicpac/meeting.html">https://www.cdc.gov/hicpac/meeting.html</a> no later
than 11:59 p.m., EDT, October 22, 2023, according to the instructions
provided on the HICPAC website. If the number of persons requesting to
speak is greater than can be reasonably accommodated during the
scheduled time, CDC will conduct a random draw to determine the
speakers for the scheduled public comment session. CDC staff will
notify individuals regarding their request to speak by email on October
30, 2023. To accommodate the significant interest in participation in
the oral public comment session of HICPAC meetings, each speaker will
be limited to three minutes, and each speaker may only speak once per
meeting.
Written Public Comment: The public is welcome to submit written
comments in advance of the meeting. The written public comment period
will open November 1, 2023, and will close at 11:59 p.m., EDT on
November 6, 2023. Comments should be submitted in writing by email to
the HICPAC inbox at <a href="/cdn-cgi/l/email-protection#a0c8c9c3d0c1c3e0c3c4c38ec7cfd6"><span class="__cf_email__" data-cfemail="741c1d17041517341710175a131b02">[email protected]</span></a>. All requests must contain the name,
address, and organizational affiliation of the speaker, as well as the
topic being addressed. Written comments should not exceed one single-
spaced typed page in length. Written comments received in advance of
the meeting will be included in the official record of the meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-22327 Filed 10-6-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.